SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
EntreMed (ENMD)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
2135 59 0 ENMD
Emcee:  Mark Wise Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
135 I got some between 7 1/8 and 3/4, my net is $9.30. The real question is who inDavid Winkler-11/27/1997
134 Reuters story implied clinical trials are a "few years away". I haveDavid Winkler-11/27/1997
133 Graham: My wife, one of my partners, and I own most of that volume (between 6.John Bloxom-11/27/1997
132 AP, Reuters, Comex, & UPI got the story in the last few hours. No mention John Bloxom-11/27/1997
131 A friend e-mailed me this article from today's Boston Globe. Evidently it wSid Turtlman-11/27/1997
130 Who bought all that stock at 6.50-8.00 a share (I am jealous)!! I had a chanceGraham Dellaire-11/26/1997
129 NEWS RELEASE ON REUTERS!!!! Entremed's Achilles heel of malignant tumours Graham Dellaire-11/26/1997
128 CNN will run it over and over for about a day. Lots of talk over turkey tomorrDavid Winkler-11/26/1997
127 Lots to be thankful for indeed. Just called the company to give 'em a headJohn Bloxom-11/26/1997
126 I have been replenishing my stocks I sold to buy enmd as purchase $ comes availDavid Winkler-11/26/1997
125 CNN HEADLINE NEWS - ENDOSTATEN REPORT My wife called just now and reported thaJohn Bloxom-11/26/1997
124 Must be some recogintion here- 11 3/4 pre holiday and good volume. Should be iDavid Winkler-11/26/1997
123 I think we're some time from any meaningful recognition by the market. NoteJohn Bloxom-11/24/1997
122 Today should be interesting. This concept has got to be attracting attention sDavid Winkler-11/24/1997
121 <<I wonder how exclusive entremed's license is? Does it include the cJohn Bloxom-11/23/1997
120 I totally agree. It doesn't take much. I held Cell Science for more than Graham Dellaire-11/23/1997
119 The newsday article was well written and accurate. Unusual for coverage of a sDavid Winkler-11/21/1997
118 Here's an article that was published on Thursday in a local New York paper,John Bloxom-11/21/1997
117 David: Thanks so much for your post. What you have set forth is consistent wiJohn Bloxom-11/20/1997
116 Some further impressions on yesterdays talk. The treatment works on ALL TUMORSDavid Winkler-11/20/1997
115 I attended the talk yesterday and will post more tonight. In one word--WOW! David Winkler-11/20/1997
114 Larry: Thanks for your post. I would be very grateful if you could post that John Bloxom-11/20/1997
113 S.F Chronicle(11/20) has article regarding Folkman's speech at NIH. He is qLarry Liebman-11/20/1997
112 << I think it will be great stock to own for 98 and 99 as clinical trialsJohn Bloxom-11/14/1997
111 What was the cummulative trading volume on ENMD when it was down? If you can wGraham Dellaire-11/13/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News